THSTI, Miltenyi Biotec and BIRAC launch India’s first hands-on training on cell and gene therapy…
The initiative focuses on building India’s capacity in CAR-T cell therapy through practical training and industry-academia…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
cell and gene therapy
FDA’s curb on overseas cell processing to hit smaller cell and gene therapy companies:…
Regulators haven’t specified how many trials are affected, though therapies like CAR-T, which sometimes use overseas manufacturing…
Cell and gene therapy market set to grow at 44% CAGR through 2030: GlobalData
GlobalData’s report reveals that CGT market for GI disorders, as a standalone therapy area, is expected to increase from $47…
East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures and Micro Labs
The funds raised will be utilised to enable several key initiatives like pre-clinical testing of CAR-NK and CAR-gamma delta T cell…
Immuneel Therapeutics welcomes Amit Mookim as CEO
Mookim will focus on establishing partnerships with providers, practitioners, and public health, and delivering current CART…
Miltenyi Biotec and Translational Health Science Institute collaborate to strengthen R&D in…
The collaboration aim to address the growing need for innovative treatments in the fight against cancer by developing innovative…
Vertex Pharma poised to dominate global gene therapy market with first CRISPR approval: GlobalData
The global cell and gene therapy market is expected to reach $80 billion in 2029, with a high CAGR of 51.6 per cent between 2023…
Avantor expands Life Sciences Innovation Center to address bioprocessing needs in protein science,…
Increased investment in bioprocessing infrastructure furthers biologics innovation and improved efficiencies in bioproduction